About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics signs license agreement to expand TPM®-based animal nutrition products to the UK and Ireland
March 25, 2015
Click here to read more
Post navigation
Previous Post
Appendix 4E Preliminary Final Financial Report
Next Post
Phosphagenics Appoints Three New Directors
Related Posts
Phosphagenics Entitlement Offer Raises Over AUD3M
October 25, 2017
Dosing commences for Phase I human clinical trial
October 4, 2021
October 4, 2021
Phosphagenics Launches New Logo and Website
November 5, 2014